Targeted therapy for cancer using pH-responsive nanocarrier systems

Most of the conventional chemotherapeutic agents used against cancer have poor efficacy. An approach to improve the efficacy of cancer chemotherapy is the development of carrier systems that can be triggered to release the anticancer drug in response to extracellular or intracellular chemical stimul...

Full description

Bibliographic Details
Main Authors: Manchun, S., Dass, Crispin, Sriamornsak, P.
Format: Journal Article
Published: Elsevier 2012
Subjects:
Online Access:http://hdl.handle.net/20.500.11937/20115
_version_ 1848750218221191168
author Manchun, S.
Dass, Crispin
Sriamornsak, P.
author_facet Manchun, S.
Dass, Crispin
Sriamornsak, P.
author_sort Manchun, S.
building Curtin Institutional Repository
collection Online Access
description Most of the conventional chemotherapeutic agents used against cancer have poor efficacy. An approach to improve the efficacy of cancer chemotherapy is the development of carrier systems that can be triggered to release the anticancer drug in response to extracellular or intracellular chemical stimuli. To this end, pH-responsive nanocarriers have been developed to target drugs either to the slightly acidic extracellular fluids of tumor tissue or, after endocytosis, to the endosomes or lysosomes within cancer cells. These systems can release the drug by specific processes after accumulation in tumor tissues via the enhanced permeability and retention (EPR) effect or they can release the drugs in endosomes or lysosomes by pH-controlled hydrolysis after they are taken up by the cell via the endocytic pathway. This strategy facilitates the specific delivery of the drug while reducing systemic side-effects with high potential for improving the efficacy of cancer chemotherapy.
first_indexed 2025-11-14T07:33:20Z
format Journal Article
id curtin-20.500.11937-20115
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T07:33:20Z
publishDate 2012
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-201152017-09-13T13:48:13Z Targeted therapy for cancer using pH-responsive nanocarrier systems Manchun, S. Dass, Crispin Sriamornsak, P. Drug delivery Nanocarrier Chemotherapy pH-responsive Cancer Most of the conventional chemotherapeutic agents used against cancer have poor efficacy. An approach to improve the efficacy of cancer chemotherapy is the development of carrier systems that can be triggered to release the anticancer drug in response to extracellular or intracellular chemical stimuli. To this end, pH-responsive nanocarriers have been developed to target drugs either to the slightly acidic extracellular fluids of tumor tissue or, after endocytosis, to the endosomes or lysosomes within cancer cells. These systems can release the drug by specific processes after accumulation in tumor tissues via the enhanced permeability and retention (EPR) effect or they can release the drugs in endosomes or lysosomes by pH-controlled hydrolysis after they are taken up by the cell via the endocytic pathway. This strategy facilitates the specific delivery of the drug while reducing systemic side-effects with high potential for improving the efficacy of cancer chemotherapy. 2012 Journal Article http://hdl.handle.net/20.500.11937/20115 10.1016/j.lfs.2012.01.008 Elsevier restricted
spellingShingle Drug delivery
Nanocarrier
Chemotherapy
pH-responsive
Cancer
Manchun, S.
Dass, Crispin
Sriamornsak, P.
Targeted therapy for cancer using pH-responsive nanocarrier systems
title Targeted therapy for cancer using pH-responsive nanocarrier systems
title_full Targeted therapy for cancer using pH-responsive nanocarrier systems
title_fullStr Targeted therapy for cancer using pH-responsive nanocarrier systems
title_full_unstemmed Targeted therapy for cancer using pH-responsive nanocarrier systems
title_short Targeted therapy for cancer using pH-responsive nanocarrier systems
title_sort targeted therapy for cancer using ph-responsive nanocarrier systems
topic Drug delivery
Nanocarrier
Chemotherapy
pH-responsive
Cancer
url http://hdl.handle.net/20.500.11937/20115